Skip to Main Content

INFORMATION FOR

Jaimie Meyer

MD, MS, FACP
Associate Professor of Medicine (Infectious Diseases, AIDS) and Epidemiology in the Department of Chronic Disease Epidemiology; Associate Program Director of Research, Infectious Diseases

Contact Information

Jaimie Meyer, MD, MS, FACP

Research Summary

Dr. Meyer's lab centers on HIV and women’s health. We inform, develop and test HIV prevention and treatment interventions specific to women who are involved in carceral systems, women with substance use disorders, and women experiencing intimate partner violence. In doing so, we aim to develop interventions that address social determinants of health and are gender-responsive and trauma-informed. We apply principles of implementation science to adapt these interventions to key contexts, including carceral settings (prison, jail, probation, parole), drug treatment centers, and domestic violence service providers. Our work includes using patient-centered decision aids on HIV pre-exposure prophylaxis (PrEP) to help women make informed choices about HIV prevention, scaling up PrEP among key populations of women, and integrating housing and health services for people who are justice-involved. We strive to build programs for social justice, empowerment, and access to services to alleviate the burden of infectious diseases among key populations.

Coauthors

Research Interests

Acquired Immunodeficiency Syndrome; Epidemiologic Methods; HIV; Prisoners; Social Justice; Women's Health; Substance-Related Disorders; Biostatistics; Intimate Partner Violence; Health Equity

Public Health Interests

Epidemiology Methods; HIV/AIDS

Selected Publications

  • 87. Infectious Disease Diversity, Equity, and Antiracism (ID2EA): A Dedicated Curriculum for Infectious Disease ProfessionalsGleeson S, Bathgate M, Frederick J, Desruisseaux M, Meyer J, Virata M, Zapata H, Shenoi S, Radin J, Golden M, Trubin P, Shaw A, Friedland G, Aoun-Barakat L. 87. Infectious Disease Diversity, Equity, and Antiracism (ID2EA): A Dedicated Curriculum for Infectious Disease Professionals Open Forum Infectious Diseases 2021, 8: s55-s55. PMCID: PMC8644171, DOI: 10.1093/ofid/ofab466.087.
  • Chapter 11 HIV pre-exposure prophylaxis for people who inject drugsShrestha R, McCoy-Redd B, Meyer J. Chapter 11 HIV pre-exposure prophylaxis for people who inject drugs 2021, 223-236. DOI: 10.1016/b978-0-323-68328-9.00011-4.
  • Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and PrisonsLoeliger K, Altice F, Desai M, Ciarleglio M, Gallagher C, Meyer J. Predictors of Linkage to and Retention in HIV Care Following Release from Connecticut Jails and Prisons Open Forum Infectious Diseases 2017, 4: s38-s38. PMCID: PMC5632019, DOI: 10.1093/ofid/ofx162.092.
  • Longitudinal gender differences in HIV and criminal justice outcomesMeyer J, Cepeda J, Altice F. Longitudinal gender differences in HIV and criminal justice outcomes Drug And Alcohol Dependence 2015, 146: e39-e40. DOI: 10.1016/j.drugalcdep.2014.09.479.
  • Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United StatesChen N, Meyer J, Springer S. Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States Infectious Disease Reports 2011, 3: 6. DOI: 10.4081/idr.2011.2362.

Clinical Trials